Search Results

Learn how the Signals Platform can facilitate breast cancer drug discovery and lead to the faster and more efficient identification of better drug candidates.

Nexus 2021 Day Two Recap: Empowering Data-Driven Science with Flexible Informatics Day Two of Revvity Signal's Nexus 2021 Informatics Virtual User Conference delivered another engaging slate of presenters – from Merck KGaA, Birla Carbon and Givaudan to Bayer, Nimbus Therapeutics and Johnson & Johnson. If you’ve registered but missed a session (or even a day...

Data and Process Driven R&D Organizations Need to Transform

When analyzing data there is often a competition between getting an analysis set up just the way you want versus implementing a consistent method across your data and organization. Often with flexible tools, it is easy to adjust the analysis, but difficult to use it repeatedly at scale. Whereas with scalable tools, once a system is setup, the difficulty of...

Nexus 2021 – Revvity Signals Virtual User Conference – kicked off today with an exciting schedule of keynotes, technology innovation spotlights, and industry case studies from companies including Merck, Janssen, Roche Diagnostics, Bayer, Gilead Science, Bristol Meyer Squibb, and more.